PZZA — Thesis Update (Q1 2026)

Recovery Is Becoming Easier to See. The Market Is Still Waiting

In April 2026, we published our Investment Thesis 2025 with one central question:

Is the market still pricing PZZA based on its past business rather than its improving operating economics?

Two months later, the core investment question has not materially changed.

What has changed is the evidence.

Q1 2026 does not introduce a new investment thesis. Instead, it provides another opportunity to test whether the original recovery narrative continues to hold.

So far, the operating data remains broadly consistent with our initial thesis.

Sales continued to grow despite a smaller outlet base. Store productivity remained resilient. Operating profitability improved further. More importantly, the business appears to be moving beyond the balance sheet repair phase toward a more fundamental question:

How will management allocate capital once financial recovery is largely complete?

From a business perspective, the turnaround appears to be progressing as expected.

The market, however, has yet to reach the same conclusion.

Despite continued operational improvement, PZZA’s share price has remained weak amid broader market pressure. At this stage, the dominant source of investment risk appears to be shifting from company-specific execution toward systematic market risk. In other words, even if operating performance continues to improve, share price performance may still be driven primarily by broader market conditions and investor sentiment rather than company fundamentals alone.

Interestingly, market behaviour does not yet suggest broad investor abandonment.

Trading activity continues to be dominated by domestic investors. However, toward the end of the observation period, a subtle change began to emerge. While the share price continued to drift lower, foreign participation became modestly more active than in previous months. Since mid-May, one foreign brokerage has shown relatively consistent buying activity.

This observation alone does not confirm institutional conviction.

Rather, it suggests that at least some investors may be beginning to monitor the recovery more closely.

At this stage, our primary interpretation remains unchanged:

The market appears to be observing the recovery—not yet re-rating it.

This update therefore revisits five key questions:

• Has the operating recovery continued?
• Does free cash flow still support the turnaround?
• Is productivity improving beyond simple network rationalization?
• Does the original valuation framework remain appropriate?
• Has market interpretation materially changed?

Our conclusion remains straightforward.

Q1 2026 does not alter the core investment thesis.

What it does is strengthen the evidence supporting it.

The recovery increasingly appears to be driven by improving operating economics rather than balance sheet repair alone. Cash generation remains sufficient to support the turnaround, while the original valuation framework continues to appear broadly appropriate.

Accordingly,

Our conviction in the recovery process has increased.

Intrinsic value appears largely unchanged.

Available now on Sobirin Research.